Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | MLYCD | O95822 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | CES1 | P23141 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | GLA | P06280 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | POLQ | O75417 | 1/20 | 0.38 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10659231 | 0.82 | ALDH1A1 (0.42) | L3MBTL1NPSR1KMT2AMEN1CYP3A4 | |
| Hydrochloric Acid SCHEMBL10674189 | 0.80 | ALDH1A1 (0.41) | L3MBTL1NPSR1KMT2AMEN1CYP3A4 | |
| SCHEMBL28300016 | 0.80 | MLYCD (0.44) | KMT2AMEN1CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL2444857 | 0.80 | KMT2A (0.47) | L3MBTL1NPSR1KMT2AMEN1CYP3A4 | |
| SCHEMBL16858007 | 0.78 | KMT2A (0.46) | L3MBTL1NPSR1KMT2AMEN1CYP3A4 | |
| SCHEMBL11793707 | 0.78 | CYP2C19 (0.41) | L3MBTL1NPSR1TDP1KMT2AMEN1 | |
| SCHEMBL9393355 | 0.77 | ALDH1A1 (0.39) | L3MBTL1KMT2AMEN1SMN1; SMN2ALDH1A1 | |
| SCHEMBL11792569 | 0.77 | CYP2C19 (0.40) | L3MBTL1NPSR1TDP1KMT2AMEN1 | |
| SCHEMBL124582 | 0.74 | NPSR1 (0.46) | L3MBTL1NPSR1TDP1KMT2AMEN1 | |
| SCHEMBL9743711 | 0.74 | NPSR1 (0.46) | L3MBTL1NPSR1TDP1KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1503 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3334759-B1 | LACTOFERRIN FRAGMENT FOR THE USE AS ANTIBACTERIAL AND ANTIVIRAL AGENT | FARMAGENS HEALTH CARE SRL (IT) | 2019-09-04 | — | — | EP | claimed |
| US-20030143664-A1 | Products of manufacture and processes for peptide synthesis | DIVERSA CORPORATION (US) | 2003-07-31 | — | — | US | claimed |
| WO-2003048189-A2 | PRODUCTS OF MANUFACTURE AND PROCESSES FOR PEPTIDE SYNTHESIS | DIVERSA CORPORATION (US) | 2003-06-12 | — | — | WO | claimed |
| US-12617818-B2 | Compositions and methods for modulating myosin subfragment-2 coiled coil stability and methods for using them | UNIVERSITY OF NORTH TEXAS (US) | 2026-05-05 | — | — | US | disclosed |
| US-20260116948-A1 | T CELL RECEPTOR CONSTRUCTS AND USES THEREOF | BIONTECH US INC (US) | 2026-04-30 | — | — | US | disclosed |
| US-20260115288-A1 | T CELL MANUFACTURING COMPOSITIONS AND METHODS | BIONTECH US INC (US) | 2026-04-30 | — | — | US | disclosed |
| US-12606530-B2 | Aniline acid anhydride, preparation method therefor, and polyamino acid-grafted chain | SOOCHOW UNIVERSITY (CN) | 2026-04-21 | — | — | US | disclosed |
| US-20260083834-A1 | CsgA-DERIVED NANOSTRUCTURES AND USES THEREOF FOR ANTIGEN DELIVERY | TRANSFERT PLUS LP (CA) | 2026-03-26 | — | — | US | disclosed |
| US-20260048116-A1 | PROTEIN ANTIGENS AND USES THEREOF | BIONTECH US INC (US) | 2026-02-19 | — | — | US | disclosed |
| EP-3365354-B1 | PEPTIDES AND PEPTIDOMIMETICS IN COMBINATION WITH T CELL ACTIVATING AND/OR CHECKPOINT INHIBITING AGENTS FOR CANCER TREATMENT | CANBAS CO LTD (JP) | 2026-02-11 | — | — | EP | disclosed |
| US-20260034223-A1 | BIOMIMETIC EXTRACELLULAR MATRIX NANOFIBERS ELECTROSPUN WITH CALRETICULIN | NEW YORK UNIVERSITY (US) | 2026-02-05 | — | — | US | disclosed |
| WO-1996040927-A1 | ISOSPORA SUIS VACCINE | AMBICO, INC. (US) | 1996-12-19 | — | — | WO | disclosed |
| EP-0745095-A1 | PEPTIDES RECOGNIZED BY MELANOMA-SPECIFIC CYTOTOXIC LYMPHOCYTES, AND USES THEREFOR | THE UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 1996-12-04 | — | — | EP | disclosed |
| US-5508384-A | NEUROLEPTIC AGENTS WITH REDUCED SIDE EFFECTS | NEW YORK UNIVERSITY (US) | 1996-04-16 | — | — | US | disclosed |
| WO-1995022561-A2 | PEPTIDES RECOGNIZED BY MELANOMA-SPECIFIC CYTOTOXIC LYMPHOCYTES, AND USES THEREFOR | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 1995-08-24 | — | — | WO | disclosed |
| WO-1995020397-A1 | PHOSPHACAN, NUCLEIC ACIDS ENCODING THEREOF AND ANTIBODIES THERETO | NEW YORK UNIVERSITY (US) | 1995-08-03 | — | — | WO | disclosed |
| WO-1995013828-A1 | BENEFICIAL WOUND HEALING APPLICATIONS OF CALRETICULIN AND OTHER HYALURONAN-ASSOCIATED PROTEINS | NEW YORK UNIVERSITY (US) | 1995-05-26 | — | — | WO | disclosed |
| WO-1995013291-A1 | NEURON-GLIA CELL ADHESION MOLECULE, NG-CAM, IN TREATMENT OF NERVE DAMAGE | NEW YORK UNIVERSITY (US) | 1995-05-18 | — | — | WO | disclosed |
| WO-1994003601-A9 | CLONING, EXPRESSION AND USES FOR NEUROCAN AS A CHONDROITIN SULFATE PROTEOGLYCAN | — | 1994-03-31 | — | — | WO | disclosed |
| WO-1994003601-A2 | CLONING, EXPRESSION AND USES FOR NEUROCAN AS A CHONDROITIN SULFATE PROTEOGLYCAN | NEW YORK UNIVERSITY (US) | 1994-02-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12606530-B2 | Aniline acid anhydride, preparation method therefor, and polyamino acid-grafted chain | BCAT1, GARS1, NGLY1 | L3MBTL1 1646/4885NPSR1 1771/4885TDP1 3236/4885 |
| US-20260115288-A1 | T CELL MANUFACTURING COMPOSITIONS AND METHODS | CD14, CD4, IL2RA | L3MBTL1 994/4885NPSR1 945/4885TDP1 3173/4885 |
| US-20260048116-A1 | PROTEIN ANTIGENS AND USES THEREOF | HLA-DRB1, MICA, TAP2 | L3MBTL1 741/4885NPSR1 3972/4885TDP1 3187/4885 |
| US-20260083834-A1 | CsgA-DERIVED NANOSTRUCTURES AND USES THEREOF FOR ANTIGEN DELIVERY | VSIG8, MICA, CD74 | L3MBTL1 126/4885NPSR1 2252/4885TDP1 3201/4885 |
| US-20260034223-A1 | BIOMIMETIC EXTRACELLULAR MATRIX NANOFIBERS ELECTROSPUN WITH CALRETICULIN | CALR, ERP44, PDIA4 | L3MBTL1 2552/4885NPSR1 2456/4885TDP1 3959/4885 |
| US-12617818-B2 | Compositions and methods for modulating myosin subfragment-2 coiled coil stability and methods for using them | MYLK2, TNNC1, MYOF | L3MBTL1 353/4885NPSR1 4457/4885TDP1 2091/4885 |
| US-20260116948-A1 | T CELL RECEPTOR CONSTRUCTS AND USES THEREOF | MICA, IGSF11, IGLV6-57 | L3MBTL1 286/4885NPSR1 3130/4885TDP1 966/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.